Results 211 to 220 of about 83,566 (244)
Some of the next articles are maybe not open access.

Targeting the Mannose Receptor with Mannosylated Subunit Vaccines

Current Medicinal Chemistry, 2014
The mannose receptor (MR) is an important component of the immune system and understanding the structural and conformational characteristics of this receptor is a key aspect of vaccine design. Improved understanding of the role of carbohydrate recognition domains 4-7 (CRDs 4-7) in recognising glycosylated ligands present on the surface of pathogens ...
Sedaghat, B., Stephenson, R., Toth, I.
openaire   +5 more sources

[Tolerance of preventive influenza vaccination with a subunit vaccine].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 1994
The frequency and intensity of undesirable side effects after protective vaccination against influenza with a commercially available vaccine were studied. 82 gainfully employed persons of both sexes were questioned in respect of local reactions such as weal and flare reactions, itching, sensation of heat, tenderness on pressure, and impeded movement ...
T A, Wagner, R, Skiba
openaire   +1 more source

Subunit Vaccine Delivery

2015
Subunit vaccine delivery , Subunit vaccine delivery , کتابخانه مرکزی دانشگاه علوم پزشکی ...
openaire   +1 more source

[Polysaccharide subunit vaccines].

La Revue du praticien, 1995
The polysaccharide capsules of many germs (pneumococcus, meningococcus, Haemophilus b, salmonella, etc.) can induce synthesis of protective antibodies in man. The development of many vaccines has been based on this phenomenon. Unfortunately, the polysaccharide antigens cannot trigger an immune response before the age of 2 years.
openaire   +1 more source

Subunit-based vaccines

2022
Salvador F. Ausar   +4 more
openaire   +1 more source

Safety and immunogenicity of a subunit influenza vaccine

2000
Objectives To evaluate safety and immunogenicity of a subunit influenza vaccine (formulation 1999–2000) in a population of young and elderly people.
Minutello M   +5 more
openaire   +2 more sources

SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways

Expert Review of Vaccines, 2022
Daniel Mekonnen   +2 more
exaly  

Home - About - Disclaimer - Privacy